Peter T. Reissmann

703 total citations
7 papers, 588 citations indexed

About

Peter T. Reissmann is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Peter T. Reissmann has authored 7 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Surgery. Recurrent topics in Peter T. Reissmann's work include Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and Cancer-related gene regulation (2 papers). Peter T. Reissmann is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (2 papers) and Cancer-related gene regulation (2 papers). Peter T. Reissmann collaborates with scholars based in United States and Japan. Peter T. Reissmann's co-authors include Dennis J. Slamon, Robert A. Figlin, E. Carmack Holmes, Carlos Cordon‐Cardo, Huiqi Pan, Wei Dai, Bin Ouyang, Hironobu Koga, Luo Lu and T. Strohmeyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and CHEST Journal.

In The Last Decade

Peter T. Reissmann

7 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter T. Reissmann United States	7	385	308	140	124	104	7	588
Shigeto Hosoe Japan	11	563 1.5×	297 1.0×	49 0.3×	95 0.8×	168 1.6×	19	826
Tony DeBlasio United States	11	575 1.5×	421 1.4×	104 0.7×	184 1.5×	74 0.7×	15	1.0k
Antònia Vinyals Spain	11	463 1.2×	331 1.1×	64 0.5×	52 0.4×	162 1.6×	17	679
PG Natali United States	5	300 0.8×	178 0.6×	75 0.5×	76 0.6×	86 0.8×	8	530
G Moëns France	12	416 1.1×	169 0.5×	112 0.8×	44 0.4×	98 0.9×	19	593
Gitali Ganguli France	8	491 1.3×	284 0.9×	66 0.5×	50 0.4×	125 1.2×	9	627
Rebecca Grochow United States	3	469 1.2×	381 1.2×	63 0.5×	51 0.4×	106 1.0×	3	730
Manfred Schwab Germany	8	336 0.9×	218 0.7×	49 0.3×	32 0.3×	142 1.4×	8	573
Henry Koo United States	5	538 1.4×	237 0.8×	50 0.4×	86 0.7×	186 1.8×	6	731
Natascha Cremers Germany	11	239 0.6×	290 0.9×	68 0.5×	63 0.5×	137 1.3×	12	516

Countries citing papers authored by Peter T. Reissmann

Since Specialization

Citations

This map shows the geographic impact of Peter T. Reissmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Reissmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Reissmann more than expected).

Fields of papers citing papers by Peter T. Reissmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter T. Reissmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Reissmann. The network helps show where Peter T. Reissmann may publish in the future.

Co-authorship network of co-authors of Peter T. Reissmann

This figure shows the co-authorship network connecting the top 25 collaborators of Peter T. Reissmann. A scholar is included among the top collaborators of Peter T. Reissmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter T. Reissmann. Peter T. Reissmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Dai, Wei, Yaqin Li, Bin Ouyang, et al.. (2000). PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer. Genes Chromosomes and Cancer. 27(3). 332–336. 53 indexed citations

2.

Reissmann, Peter T., Hironobu Koga, Robert A. Figlin, E. Carmack Holmes, & Dennis J. Slamon. (1999). Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 125(2). 61–70. 92 indexed citations

3.

Li, Bo, Bin Ouyang, Huiqi Pan, et al.. (1996). prk, a Cytokine-inducible Human Protein Serine/Threonine Kinase Whose Expression Appears to be Down-regulated in Lung Carcinomas. Journal of Biological Chemistry. 271(32). 19402–19408. 124 indexed citations

4.

Levin, Wendy J., Michael F. Press, Richard B. Gaynor, et al.. (1995). Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.. PubMed. 11(7). 1261–9. 101 indexed citations

5.

Levin, Wendy J., et al.. (1994). Tumor Suppressor and Immediate Early Transcription Factor Genes in Non-small Cell Lung Cancer. CHEST Journal. 106(6). 372S–376S. 12 indexed citations

6.

Reissmann, Peter T., HISAMITSU KOGA, Rie Takahashi, et al.. (1993). Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.. PubMed. 8(7). 1913–9. 112 indexed citations

7.

Strohmeyer, T., Peter T. Reissmann, Carlos Cordon‐Cardo, et al.. (1991). Correlation between retinoblastoma gene expression and differentiation in human testicular tumors.. Proceedings of the National Academy of Sciences. 88(15). 6662–6666. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact